Arkolith/Insider Trading/OVID/Form 4/A

Levin Jeremy M

CEO, DirectorOvid Therapeutics Inc. (OVID) · full profile →Form 4/A · filed Feb 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2019Gift(G)465K—$00

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001415889-24-003721) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML